TAIWAN · TWSE / TPEx
Mycenax
永昕 · 4726 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$22.851 month +1.1% · 1 year -39.1%
Directors and supervisors hold43,624,69521.1% of shares issued
Of which pledged33.9%14,800,000
Major shareholders (10%+) hold83,314,31440.2% of shares issued
Revenue, 2026-09+393.3%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 晟德大藥廠股份有限公司 | Chairman · Director · Major shareholder (10%+) | 41,974,314 | 42,094,314 | 20.33% | 14,800,000 | — |
| 陳佩君 | Chairman (corporate representative) · President | — | 1,300,000 | 0.63% | — | — |
| 陳俊宏 | Director (corporate representative) | — | 0 | — | — | — |
| 佳軒科技股份有限公司 | Director | 1,302,674 | 1,302,674 | 0.63% | — | — |
| 林榮錦 | Director (corporate representative) | — | 0 | — | — | 4,584 |
| 中加投資發展股份有限公司 | Director | 227,707 | 227,707 | 0.11% | — | — |
| 李懿欣 | Director (corporate representative) | — | 0 | — | — | — |
| 高國彬 | Independent director | — | 0 | — | — | — |
| 蔡育盛 | Independent director | — | 0 | — | — | — |
| 顏國隆 | Independent director | — | 0 | — | — | — |
| 劉邦良 | Vice president | — | 0 | — | — | — |
| 周維宜 | Assistant vice president | — | 150,000 | 0.07% | — | 2,000 |
| 梁晉豪 | Assistant vice president | — | 5,000 | 0.00% | — | — |
| 葉麗如 | Assistant vice president · Chief financial officer · Other | — | 0 | — | — | — |
| 林宥穠 | Assistant vice president | — | 86,000 | 0.04% | — | — |
| JCR Pharmaceuticals Co., Ltd. | Major shareholder (10%+) | — | 41,220,000 | 19.91% | — | — |
| 李家誠 | Chief accountant | — | 0 | — | — | — |